Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Assets (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Other Non-Current Assets for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 0.0% change, with the full-year FY2025 number at $1.5 million, changed 0.0% from a year prior.
  • Other Non-Current Assets was $1.5 million for Q4 2025 at Pliant Therapeutics, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.5 million in Q4 2023 to a low of $391000.0 in Q2 2025.
  • A 5-year average of $1.1 million and a median of $1.5 million in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 85.14% in 2022, then crashed 73.62% in 2025.
  • Pliant Therapeutics' Other Non-Current Assets stood at $831000.0 in 2021, then tumbled by 52.23% to $397000.0 in 2022, then skyrocketed by 273.3% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Other Non-Current Assets are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $391000.0 (Q2 2025).